Neutrophil-lymphocyte ratio as a predictive biomarker for response to high dose interleukin-2 in patients with renal cell carcinoma

BACKGROUND: Immunotherapy with high-dose interleukin-2 (HD-IL2) results in long-term survival in some metastatic renal cell carcinoma (mRCC) patients but has significant acute toxicities. Biomarkers predicting response to therapy are needed to better select patients most likely to benefit. NLR (abso...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuzman, James A., Stenehjem, David D., Merriman, Joseph, Agarwal, Archana M., Patel, Shiven B., Hahn, Andrew W., Alex, Anitha, Albertson, Dan, Gill, David M., Agarwal, Neeraj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217571/
https://www.ncbi.nlm.nih.gov/pubmed/28056941
http://dx.doi.org/10.1186/s12894-016-0192-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217571/
https://www.ncbi.nlm.nih.gov/pubmed/28056941
http://dx.doi.org/10.1186/s12894-016-0192-0

Ejemplares similares